| Acute pyeloneprhitis | CAP | Intraabdominal infections | Primary bacteremia | VAP/HAP | P |
---|---|---|---|---|---|---|
Total number | 183 | 97 | 100 | 61 | 64 | Â |
Male/female | 86/97 | 61/36 | 51/39 | 41/20 | 41/23 | 0.011 |
Age (years, mean ± SD) | 67.3 ± 17.1 | 68.4 ± 19.7 | 54.1 ± 24.5 | 64.0 ± 16.3 | 70.6 ± 14.5 | <0.0001 |
APACHE II (mean ± SD) | 11.7 ± 6.8 | 15.7 ± 8.8 | 12.7 ± 7.7 | 18.2 ± 7.5 | 20.0 ± 5.4 | <0.0001 |
White blood cells (/μl, mean ± SD) | 15684.3 ± 11481.3 | 15002.2 ± 7272.8 | 15595.7 ± 7027.8 | 13755.9 ± 9551.8 | 13905.7 ± 8289.2 | NS |
Sepsis/severe sepsis-shock | 141/42 | 56/41 | 70/30 | 23/38 | 22/42 | <0.0001 |
Death (number, %) | 14 (7.7) | 30 (30.9) | 16 (16.0) | 21 (34.4) | 22 (34.4) | <0.0001 |
Pathogen* (number, %) | Â | Â | Â | Â | Â | 0.039 |
Escherichia coli | 71 (38.7) | - | 3 (3.0) | 12 (19.7) | 0 (0) | Â |
Pseudomonas aeruginosa | 18 (9.8) | - | 3 (3.0) | 20 (32.8) | 15 (23.5) | Â |
Klebsiella pneumoniae | 12 (6.6) | - | 2 (2.0) | 12 (19.7) | 0 (0) | Â |
Acinetobacter baumannii | 3 (1.6) | - | 0 (0) | 10 (16.3) | 14 (21.9) | Â |
Other Gram-negatives | 9 (4.9) | - | 0 (0) | 7 (11.5) | 1 (1.6) | Â |
Enterococcus faecalis | 6 (3.3) | Â | Â | 1 (1.6) | Â | Â |
Other Gram(+) cocci | 5 (2.7) | 7 (7.2) | 2 (2.0) | 4 (6.5) | 0 (0) | Â |
Co-morbidities (number, %) | Â | Â | Â | Â | Â | 0.045 |
Diabetes mellitus type 2 | 48 (26.2) | 19 (19.6) | 19 (19.0) | 16 (26.2) | 14 (21.9) | Â |
Heart failure | 23 (12.6) | 14 (14.4) | 9 (9.0) | 13 (21.3) | 11 (17.2) | Â |
COPD | 15 (8.2) | 20 (20.6) | 5 (5.0) | 8 (13.1) | 9 (14.1) | Â |
Chronic renal disease | 17 (9.3) | 6 (6.2) | 3 (3.0) | 8 (13.1) | 7 (10.9) | Â |